A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
RATIONALE: Lymphadenectomy may remove tumour cells that have spread to nearby lymph nodes in
patients with invasive bladder cancer. It is not yet known whether extended pelvic
lymphadenectomy is more effective than standard pelvic lymphadenectomy during surgery.
PURPOSE: This randomized phase II trial is studying standard pelvic lymphadenectomy to see
how well it works compared to extended pelvic lymphadenectomy in treating patients
undergoing surgery for invasive bladder cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society